February 11, 2011 | Filed under: Health,News | Posted by:
The experimental anti-clotting drug apixaban beat aspirin at preventing dangerous clots or strokes in people with the abnormal heart rhythm atrial fibrillation, according to final results of the so-called AVERROES trial.
Posted by
on February 11, 2011. Filed under Health, News.
You can follow any responses to this entry through the RSS 2.0.
You can leave a response or trackback to this entry
Posted by
on February 11, 2011. Filed under